Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer

Synonyms:   CP-690550 (Tofacitinib citrate);(3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate CAS No.: 540737-29-9 Quality: in house Molecular Formula:  C16H20N6O.C6H8O7 Formula Weight:  504.49

Products Details

Payment: T/T, L/C Product Origin: China Shipping Port: Beijing/Shanghai/Hangzhou Production capacity: 100kg/month Order(MOQ): 25kg Lead Time: 3 Working Days Storage condition: Stored in cool, dry place, room temperature. Package material: drum Package size: 25kg/drum Safety information:  Not dangerous goods

Item

Specification

Appearance

White or off-white crystalline powder

Identification

IR, HPLC

Water

≤1.5%

Related Substances

TOFA 06 ≤0.15%

Tofacitinib trans isomer ≤0.15%

Tofacitinib dehydrogenated ≤0.15%

Each unknown impurity ≤0.10%

Total Impurities: ≤1.0%

Residual Solvents

Ethanol ≤5000ppm

Benzene ≤2ppm

Toluene ≤890ppm

Chlroroethane ≤1000ppm

N,N-Dimethylformamide ≤800ppm

Palladium ≤10ppm

Dichloromethane ≤600ppm

Sulphated ash

≤0.1%

Heavy Metal

≤10ppm

Chrial HPLC

3S, 4S tofacitinib ≤0.15%

Assay (on anhydrous basis) 98.0-102.0%

Tofacitinib, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Tofacitinib citrate is used to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate. Tofacitinib citrate is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours